Serum and Saliva Concentrations of Biochemical Parameters in Men with Prostate Cancer and Benign Prostate Hyperplasia
- 7 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 51 (3), 243-251
- https://doi.org/10.1093/labmed/lmz053
Abstract
Objectives To find suitable biomarkers for diagnosis of prostate cancer (PC) in serum and saliva; also, to evaluate the diagnostic efficacy of saliva in patients with PC. Methods This case-control study included 20 patients with PC and 20 patients with benign prostatic hyperplasia (BPH). Blood and saliva were collected from the participants and centrifuged. Serum and supernatant saliva were used for biochemical analysis. We evaluated serum and salivary levels of urea, creatinine, prostate-specific antigen (PSA), creatine kinase BB (CK-BB), zinc, β-2 microglobulin (B2M), and melatonin. Also, we used Mann-Whitney U testing, Spearman correlation coefficients, and receiver operating characteristic (ROC) analysis to evaluate the data. Results Serum and salivary concentrations of urea, creatinine, PSA, CK-BB, zinc, and B2M were significantly higher in patients with PC, compared with the BPH group (P <.05). However, serum and salivary concentrations of melatonin were significantly lower in patients with PC, compared with BPH group (P <.05). In both groups, salivary concentrations of all markers were lower (P <.05), compared with those values in serum. We observed positive correlation between serum and salivary concentrations of all markers studied (P <.05). Conclusion From the data, we conclude that investigation using saliva specimens is a noninvasive, simple, and effective tool for screening of biochemical parameters.Keywords
Funding Information
- Deputy of Research and Technology
- Arak University of Medical Sciences (2135)
This publication has 50 references indexed in Scilit:
- Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysisThe International Journal of Biochemistry & Cell Biology, 2013
- Low Serum Creatine Kinase Levels in Breast Cancer Patients: A Case-Control StudyPLOS ONE, 2013
- Melatonin Anticancer Effects: ReviewInternational Journal of Molecular Sciences, 2013
- Zinc status of patients with benign prostatic hyperplasia and prostate carcinomaIndian Journal of Urology, 2011
- Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP modelJournal of Pineal Research, 2010
- Serum Creatinine and Prostate Cancer Risk in a Prospective StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Recent Advances in the Detection of Prostate Cancer Using Epigenetic Markers in Commonly Collected Laboratory SamplesLaboratory Medicine, 2009
- β2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP–Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor AxisClinical Cancer Research, 2006
- Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon CancerCancer Research, 2006
- The presence of creatine kinase bb isoenzyme in patients with prostatic cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1980